Skip to main content

and
  1. Article

    Open Access

    Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection

    We investigated the crystal structure of an HLA-A*2402-restricted CTL epitope in the HIV-1 nef gene (Nef134-10) before (pHLA) or after TCR docking. The wild type epitope and two escape mutants were included in th...

    Akihisa Shimizu, Ai Kawana-Tachikawa, Atsushi Yamagata, Chungyong Han in Scientific Reports (2013)

  2. Article

    Open Access

    Switching and emergence of CTL epitopes in HIV-1 infection

    Human Leukocyte Antigen (HLA) class I restricted Cytotoxic T Lymphocytes (CTLs) exert substantial evolutionary pressure on HIV-1, as evidenced by the reproducible selection of HLA-restricted immune escape muta...

    Chungyong Han, Ai Kawana-Tachikawa, Akihisa Shimizu, Dayong Zhu in Retrovirology (2014)

  3. Article

    Open Access

    Selective killing of malignant B cells using T cells redirected against malignancy variant receptor

    Chungyong Han, Sujung Sim, Kwang Hui Kim in Journal for ImmunoTherapy of Cancer (2014)

  4. No Access

    Article

    4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8+ T cell proliferation

    4-1BB (CD137) is a strong enhancer of the proliferation of CD8+ T cells. Since these cells require increased production of energy and biomass to support their proliferation, we hypothesized that 4-1BB signaling a...

    Beom K Choi, Do Y Lee, Don G Lee, Young H Kim in Cellular & Molecular Immunology (2017)

  5. Article

    Open Access

    Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression

    Chimeric antigen receptor (CAR) T cell therapy is an effective method for treating specific cancers. CARs are normally designed to recognize antigens, which are highly expressed on malignant cells but not on T...

    Chungyong Han, Su-Jung Sim, Seon-Hee Kim, Rohit Singh in Nature Communications (2018)

  6. Article

    Open Access

    Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses

    The antitumor capabilities of agonistic anti-4-1BB mAbs have made them an attractive target for tumor immunotherapy. However, the adverse side effects associated with agonist antibodies have hindered their cli...

    Seon-Hee Kim, Rohit Singh, Chungyong Han, Eunjung Cho in Cellular & Molecular Immunology (2021)

  7. Article

    Open Access

    Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rαhi CD8+ T cells

    Adoptive T cell therapy (ACT) requires lymphodepletion preconditioning to eliminate immune-suppressive elements and enable efficient engraftment of adoptively transferred tumor-reactive T cells. As anti-CD4 mo...

    Seon-Hee Kim, Eunjung Cho, Yu I. Kim, Chungyong Han, Beom K. Choi in Nature Communications (2021)

  8. No Access

    Article

    Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1

    We previously found the SLC3A2-NRG1 (S-N) fusion gene in a lung adenocarcinoma specimen without known driver mutations and validated this in 59 invasive mucinous adenocarcinoma (IMA) samples. Interestingly, KRAS ...

    Dong Hoon Shin, Sun Ha Kim, Minyoung Choi, Young-Ki Bae, Chungyong Han in Oncogene (2022)

  9. Article

    Open Access

    4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell

    Eunjung Cho, Rohit Singh, Chungyong Han, Seon-Hee Kim in Cellular & Molecular Immunology (2023)